Search

Your search keyword '"Lau CE"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Lau CE" Remove constraint Author: "Lau CE"
99 results on '"Lau CE"'

Search Results

1. How do metabolic processes age: Evidence from human metabolomic studies

2. Two procedures establishing preference for oral cocaine and lidocaine solutions which do not use an associative history with a reinforcer

3. A schedule induction probe technique for evaluating abuse potential: comparison of ethanol, nicotine and caffeine, and caffeine-midazolam interaction

5. Oral cocaine as a reinforcer

8. Reported Incidence of Infections Caused by Pathogens Transmitted Commonly Through Food: Impact of Increased Use of Culture-Independent Diagnostic Tests - Foodborne Diseases Active Surveillance Network, 1996-2023.

9. NMR metabolomic modeling of age and lifespan: A multicohort analysis.

10. NMR metabolomic modelling of age and lifespan: a multi-cohort analysis.

11. How do metabolic processes age: Evidence from human metabolomic studies.

12. Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.

13. Associations of four biological age markers with child development: A multi-omic analysis in the European HELIX cohort.

14. Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: A panel study.

15. Multi-omics signatures of the human early life exposome.

16. Blood pressure interactions with the DASH dietary pattern, sodium, and potassium: The International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP).

17. Automated Annotation of Untargeted All-Ion Fragmentation LC-MS Metabolomics Data with MetaboAnnotatoR.

18. Urinary metabolic biomarkers of diet quality in European children are associated with metabolic health.

19. Transfusion with Cryoprecipitate for Very Low Fibrinogen Levels Does Not Affect Bleeding or Survival in Critically Ill Cirrhosis Patients.

20. Variability of multi-omics profiles in a population-based child cohort.

21. Metabolic profiles of socio-economic position: a multi-cohort analysis.

22. DNA methylation age as a biomarker for cancer.

23. Urinary metabolite quantitative trait loci in children and their interaction with dietary factors.

24. Metabolic Signatures of Gestational Weight Gain and Postpartum Weight Loss in a Lifestyle Intervention Study of Overweight and Obese Women.

26. In utero and childhood exposure to tobacco smoke and multi-layer molecular signatures in children.

27. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia.

28. The association of fish consumption and its urinary metabolites with cardiovascular risk factors: the International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP).

29. Exploring Cancer Metabolism: Applications of Metabolomics and Metabolic Phenotyping in Cancer Research and Diagnostics.

30. Imputation of partial pressures of arterial oxygen using oximetry and its impact on sepsis diagnosis.

31. Determinants of the urinary and serum metabolome in children from six European populations.

32. Human Early Life Exposome (HELIX) study: a European population-based exposome cohort.

33. Assessment of metabolic phenotypic variability in children's urine using 1 H NMR spectroscopy.

34. Metabolomic characterisation of the effects of oncogenic PIK3CA transformation in a breast epithelial cell line.

35. The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration-effect relations.

36. The pharmacokinetic determinants of the frequency and pattern of intravenous cocaine self-administration in rats by pharmacokinetic modeling.

37. Arteriovenous serum cocaine concentration difference after intravenous bolus injection and constant-rate infusions: relation to pharmacodynamic estimates in rats.

38. Simultaneous pharmacokinetic modeling of cocaine and its metabolites, norcocaine and benzoylecgonine, after intravenous and oral administration in rats.

39. Spontaneous activity as a contingency-controlled behavior within an operant context: alprazolam concentration-effect relations after subcutaneous administration in rats.

40. Two procedures establishing preference for oral cocaine and lidocaine solutions which do not use an associative history with a reinforcer.

41. Negligible tolerance produced by chronic intravenous alprazolam administration: a low serum drug concentration effect.

42. Contribution of the active metabolite, norcocaine, to cocaine's effects after intravenous and oral administration in rats: pharmacodynamics.

43. Oral cocaine pharmacokinetics and pharmacodynamics in a cumulative-dose regimen: pharmacokinetic-pharmacodynamic modeling of concurrent operant and spontaneous behavior within an operant context.

44. High-performance liquid chromatographic determination of cocaine and its metabolites in serum microsamples with fluorimetric detection and its application to pharmacokinetics in rats.

45. Intravenous and oral clozapine pharmacokinetics, pharmacodynamics, and concentration-effect relations: acute tolerance.

46. Post-injection delays in experimental chambers, but not in home cages, produce both sensitization and tolerance of operant behaviour to midazolam: relation to pharmacokinetics.

47. Establishing preference for lidocaine solution to water: comparison between a fading and an abrupt-removal procedure for withdrawing a compound vehicle.

48. Determination of zolpidem in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats.

49. Pharmacokinetic determinants of cocaine's differential effects on locomotor and operant behavior.

50. A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration.

Catalog

Books, media, physical & digital resources